The World Health Organization (WHO) has approved China’s Sinovac Covid-19 vaccine for emergency use.
The Organization says it will now be able to significantly boost its supply of vaccines to the Covax-facility, after green-lighting the use of the vaccine.
The WHO’s prof. Katherine O’Brien says clinical trials have shown that up to 51% of people – vaccinated with Sinovac – developed a less severe form of the virus.
O’Brien says this is the second Chinese vaccine, after Sinopharm, to receive WHO-approval.
Read more here.
Related articles:
- WHO concerned about increase in Covid-19 infections in sub-Saharan African countries.
- [Listen]: W.H.O calls for international Pandemic Treaty.
- WHO: Surge in Covid-19 infections contributes to shortfall in Covid-19 vaccine-doses to Covax-facility.
Live Q&A on SinoVac & other #COVID19 vaccines with Dr @Kate_L_OBrien & Dr Alejandro Cravioto! #AskWHO https://t.co/PqYZV7Vr98
— World Health Organization (WHO) (@WHO) June 3, 2021
